Indoleamine 2, 3-dioxygenase based immunotherapy

Details for Australian Patent Application No. 2009253539 (hide)

Owner Herlev Hospital

Inventors Straten, Per Thor; Andersen, Mads Hald

Agent FB Rice

Pub. Number AU-A-2009253539

PCT Pub. Number WO2009/143843

Priority PA 2008 00565 17.04.08 DK

Filing date 17 April 2009

Wipo publication date 3 December 2009

International Classifications

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 38/08 (2006.01) Medicinal preparations containing peptides - Peptides having 5 to 11 amino acids

A61K 38/10 (2006.01) Medicinal preparations containing peptides - Peptides having 12 to 20 amino acids

A61K 38/44 (2006.01) Medicinal preparations containing peptides

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

18 November 2010 PCT application entered the National Phase

  PCT publication WO2009/143843 Priority application(s): WO2009/143843

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009253540-Fitting for hooved and cloven-hooved animals

2009253526-Device for reducing pathogenic microbes